ArticleBritish journal of haematology2026

Incidence of severe COVID-19 in patients with chronic lymphocytic leukaemia or indolent B-cell non-Hodgkin lymphoma who received vaccination and pre-exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the GIMEMA working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi.

Gian Matteo Rigolin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.